Skandinaviska Enskilda Banken (SEB)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,700
Closed -$2.33M 403
2025
Q4
$2.33M Sell
34,700
-2,600
-7% -$175K 0.01% 550
2025
Q3
$2.74M Sell
37,300
-13,700
-27% -$910K 0.01% 519
2025
Q2
$2.65M Sell
51,000
-16,900
-25% -$962K 0.01% 533
2025
Q1
$4.33M Buy
67,900
+35,800
+112% +$2.08M 0.02% 443
2024
Q4
$1.54M Sell
32,100
-15,527
-33% -$796K 0.01% 612
2024
Q3
$2.72M Buy
47,627
+46,700
+5,038% +$2.68M 0.01% 533
2024
Q2
$48.5K Buy
+927
New +$40.7K ﹤0.01% 739
2023
Q3
Sell
-11,087
Closed -$400K 956
2023
Q2
$400K Sell
11,087
-5,000
-31% -$171K ﹤0.01% 807
2023
Q1
$614K Buy
16,087
+4,506
+39% +$211K ﹤0.01% 753
2022
Q4
$659K Sell
11,581
-19,193
-62% -$983K 0.01% 709
2022
Q3
$1.22M Sell
30,774
-22,624
-42% -$1M 0.01% 637
2022
Q2
$2.35M Hold
53,398
0.02% 529
2022
Q1
$2.13M Sell
53,398
-269,685
-83% -$9.61M 0.01% 613
2021
Q4
$13M Sell
323,083
-21,219
-6% -$792K 0.07% 242
2021
Q3
$14M Buy
344,302
+148,588
+76% +$6.21M 0.08% 237
2021
Q2
$8.89M Hold
195,714
0.05% 305
2021
Q1
$8.16M Buy
195,714
+134,614
+220% +$6.15M 0.05% 307
2020
Q4
$2.61M Sell
61,100
-19,500
-24% -$701K 0.02% 547
2020
Q3
$2.12M Buy
80,600
+48,300
+150% +$1.35M 0.02% 556
2020
Q2
$866K Buy
+32,300
New +$729K 0.01% 741

Other funds holding HALO

Skandinaviska Enskilda Banken (SEB)'s HALO Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Halozyme (HALO) in Q1 2026, closing a stake of 34,700 shares — an estimated $2.33M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in HALO in Q2 2020 and held it in 20 quarters. The position peaked at $14M in Q3 2021. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 34,700 Halozyme shares in Q1 2026, an estimated $2.33M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Halozyme in Q2 2020 and held it in 20 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Halozyme position peaked at $14M in Q3 2021.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.